Panelists stress that timely and accurate diagnosis of KMT2A-rearranged acute myeloid leukemia (AML) is essential for personalized treatment planning, highlighting the need to overcome systemic delays ...
A panelist discusses how education and cost are key challenges in ensuring comprehensive molecular testing is performed in a timely manner for patients with ovarian cancer, emphasizing the need for ...
Trends in Lung Cancer Incidence and Mortality (1990-2019) in the United States: A Comprehensive Analysis of Gender and State-Level Disparities A total of 7,413 tumor specimens were tested. The ...
Molecular diagnostics are well-established in clinical medicine. Nonetheless, the markets for these tests remain one of the most attractive growth opportunities in the in vitro diagnostics industry.
The illustration of protein structure (domains) on the left side, and corresponding exons in the FLT3 gene are displayed on the right side. FMS-like tyrosine kinase 3 (FLT3) mutations represent some ...
Effective strategies are needed to facilitate the prompt diagnosis and treatment of tuberculosis in countries with a high burden of the disease. We conducted a cluster-randomized trial in which ...
We reviewed electronic medical records of patients with newly diagnosed, untreated metastatic NSCLC from December 2018 to August 2021 and determined the number of days from pathologic diagnosis to NGS ...
Molecular diagnostics market size to reach USD 38.01 billion by 2034: Polaris Market Research: United States Thursday, February 19, 2026, 09:00 Hrs [IST] The molecular diagnostics ...
ST. PAUL, Minn. and VANCOUVER, Wash., Dec. 18, 2023 /PRNewswire/ -- Intending to reshape the landscape of at-home medical diagnostic testing, GRIP Molecular Technologies (GRIP) and Molecular Testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results